Aluminium toxicity: Its relationship with bone and iron metabolism

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 3, 1996, Pages 69-73

  Cannata Andia J B ^a,b  

^a UNIVERSITY OF OVIEDO   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Aluminium; Bone; Desferrioxamine; Erythropoietin; Hormone; Iron; Parathyroid

Indexed keywords

ALUMINUM;

BONE METABOLISM; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; ERYTHROPOIESIS; IRON METABOLISM; PRIORITY JOURNAL; TOXICITY;

EID: 0029774258     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp3.69     Document Type: Conference Paper

References (75)

1. Malluche H, Moniere-Faugere MC. Risk of adynamic bone disease in dialyzed patients. Kidney Int 1992; 42 (suppl 38): 562-567
2. Goodman WG. Ramirez JA, Belin RB et al. Development of adynamic bone in patients with secondary hyperparathyroidism after intermitent calcitriol therapy. Kidney Int 1994; 46: 1160-1166
3. Cannata JB, Douthat W, Acuña G. Aluminium toxicity. The role of prevention. Life Chem Rep 1994; 11: 207-213
4. Fournier A, Morinière PH. Mariè A. Adynamic bone disease - is it actually a disease? Nephrol Dial Transplant 1995; 10: 454-457
5. Cannata JB, Gomez Alonso C, Grosso S, Altadill A, Díaz López JB. Osteodistrofia Renal: Clasificación y concepto actual. Nefrologia 1995; 15 (Suppl 1): 20-24
6. Pei Y, Hercz G, Greenwood C et al. Risk factors for renal osteodistrophy: a multifactorial analysis. J Bone Min Res 1995; 10: 149-156
7. Cannata JB, Díaz López JB. Insights into complex aluminium and iron relationship. Nephrol Dial Transplant 1991; 6: 605-607
8. Cannata JB, Fernandez Soto I, Fernandez Menendez MJ. Fernandez Martin JL, McGregor S, Brock JH, Halls D. Role of iron metabolism in absorption and cellular uptake of aluminium. Kidney Int 1991; 39: 799-803
9. McGregor S, Naves ML, Oria R, Vass K, Brock J. Effect of aluminium on iron uptake and transferrin-receptor expression in human erythroleukaemia K562 cells. Biochem J 1990; 272: 377-382
10. Drüeke T. Adynamic bone disease, anaemia, resistance to erythropoietin and iron-aluminium interaction. Nephrol Dial Transplant 1993; 8 (suppl 1): 12-16
11. Boyce BF, Elder HY, Elliot HL et al. Hypercalcaemic osteomalacia due to aluminium toxicity. Lancet 1982; 1009-1013
12. Cannata JB, Briggs JD, Junor BJR, Gordons SF, Beastall G. Effect of acute aluminium overload on calcium and parathyroid hormone metabolism. Lancet 1983; 1: 501-503
13. Cournot-Witmer G, Plachot JJ, Bordeau A et al. Effect of aluminium on bone and cell localization. Kidney Int 1986; 29 (Suppl 18): 37-40
14. Goodman W. Experimental aluminium-induced bone disease: studies in vivo. Kidney Int 1986; 29 (Suppl 18): 32-36
15. Morrisey J, Rothstein M, Mayor G, Slatopolsky E. Suppression of parathyroid hormone secretion by aluminium. Kidney Int 1983; 23: 699-704
16. Bordeau A, Boudon R, Kindermans C, Sachs C. Effects of aluminium addition on parathyroid tissue incubation medium composition. Kidney Int 1986; 29: 924-926
17. Pun KK, Ho PW, Lau P. Effects of aluminum on the parathyroid hormone receptors of bone and kidney. Kidney Int 1990; 37: 72-78
18. Rodriguez M, Felsenfeld A, Llach F. Aluminum administration in the rat separately affects the osteoblast and bone mineralization. J Bone Min Res 1990; 5: 59-67
19. Goodman W, O'Connor J. Aluminum alters calcium influx and efflux from bone in vitro. Kidney Int 1991; 39: 602-607
20. Rodriguez M, Lorenzo V, Felsenfeld A, Llach F. Effect of parathyroidectomy on aluminum toxicity and azotemic bone disease in the rat. J Bone Min Res 1990; 5: 379-386
21. Felsenfeld A, Machado L, Rodriguez M. The effect of high parathyroid hormone levels on the development of aluminum-induced osteomalacia in the rat. J Am Soc Nephrol 1991; 1: 970-979
22. Blumenthal NC, Posner AS. In vitro model of aluminum-induced osteomalacia: inhibition of hydroxyapatite formation and growth. Calcif Tissue Int 1984; 36: 439-441
23. Talwar H, Hari Redi A, Menczel J, Thomas Jr W, Meyer J. Influence of aluminum on mineralization during matrix-induced bone development. Kidney Int 1986; 29: 1038-1042
24. Blair HC, Finch JL, Avioli R, Crouch EC, Slatopolsky E, Teilelbaum SL. Micromolar aluminum levels reduce 3H-thymidine incorporation by cell line UMR-106. Kidney Int 1989; 35: 1119-1125
25. Andress D, Felsenfeld A, Voigts A, Llach F. Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. Kidney Int 1983; 24: 364-370
26. Kraut J, Shinaberger J, Singer FR et al. Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia. Kidney Int 1983; 23: 725-730
27. Berland Y, Charbit M, Henry J, Toga M, Cano J, Olmer M. Aluminium overload of parathyroid glands in hemodialysis patients with hyperparathyroidism: Effect on bone remodelling. Nephrol Dial transplant 1988; 3: 417-422
28. Cann CE, Prussin SG, Cordan GS. Aluminium uptake by the parathyroid glands. J Clin Endocrin Metab 1979; 49: 543-545
29. Verbueken AH, Van de Vyver FL, Visser WJ, Roels F, Van Grieken RE, De Broe ME. The use of laser microprobe mass analysis (LAMMA) for localising multiple elements in soft and hard tissues. Biol Trace Elem 1987; 13: 397-412
30. Diaz López JB, D'Haese PC, Novewen EJ, Lambert LV, Cannata JB, De Broe ME. Estudio del contenido de aluminio en paratiroides de ratas con insuficiencia renal e intoxicacion aluminica crónica. Nefrologia 1988; 3: 35-41
31. Virgos MJ, Gómez Alonso C, Díaz Lopez JB, Cannata JB. Inhibitión directa de la hiperaluminemia sobre la función paratiroidea. ¿Efecto dosis-dependiente? Nefrologia 1990; 10: 101-102
32. Virgos MJ, Diaz López JB, Menendez Fraga P, Gómez Alonso C, Cannata JB. Parathyroid and serum calcium response in acute aluminium exposure in renal failure. Trace Elem Med 1994; 11: 68-72
33. Brown EM, Gamba G, Riccardi D, Lombardi M, Botters R, Kig-or O, Sum A, Hediger MA, Lytton J, Hebert S. Cloning and characterization of an extracellular Ca sensing receptor fon bovine parathyroid. Nature 1993; 366: 575-580
34. Cannata JB, Díaz López JB, Fernandez Menendez MJ, Virgós MJ. The parathyroid gland and aluminum overload: an over-view. Contrib Nephrol 1988; 64: 113-119
35. Sherrard D, Hercs G, York P, Maloney N, Greenwood C, Arif M, Saiphoo C, Fenton S, Segre G. The spectrum of bone disease in end-stage renal failure. An evolving disorder. Kidney Int 1993; 43: 436-442
36. Cannata JB, Briggs JD, Junor BJR, Beastall G, Fell GS. The influence of aluminium on parathyroid hormone levels in haemodialysis patients. Proc Eur Dial Transplant Assoc 1982; 19: 244-247
37. Cannata JB, Díaz de Greñu MC, Díaz López B, Lamas J. Hipofunción paratiroidea en la intoxicación alumínica: Análisis de factores implicados. Nefrologia 1986; 6 (Suppl 19): 57-61
38. Fernández E, Amoedo ML, Montoliu J. Level-dependent inhibitory effect of hyperaluminaemia on parathyroid hormone secretion in patients with end-stage renal failure. Eur J Med 1992; 482-484
39. Jorgetti V, Ricco Soeiro M, Mendez V et al. Aluminium-related osteodistropy and desferrioxamine treatment: role of phosphorus. Nephrol Dial Transplant 1994; 9: 668-674
40. Felsenfeld A, Harrelson J, Gutman R, Wells S, Drezner M. Osteomalacia after parathyroidectomy in patients with uremia. Ann Int Mad 1982; 96: 34-39
41. Pizzarelly F, Girdano R, Ballanti P, Constantini S, Mocetty P, Maggiore Q. Bone aluminum intoxication: an unpreventable sequel of parathyroidectomy? Nephron 1988; 48: 250-251
42. Drúcke T, Lacour B, Touam M, Basile C, Bourdon R. Oral aluminium administration to uremic, hyperparathyroid or vitamin-D supplemented rats. Nephron 1985; 39: 10-17
43. Pizzarelly F, Ballanti P, Constantini S et al. Aluminium bone content in dialysis osteodystrophy with secondary hyperparathyroidism. Min Electrolyte Metab 1988; 14: 129-134
44. Trapp GA. Plasma aluminium is bound to transferrin. Life Sci 1983;33:311-316
45. Pérez Parajón J, Blanco González E, Cannata JB, Sanz Medel A. A critical appraisal of the speciation of aluminium in serum by ultrafiltration. Trace Elem Med 1989; 6: 41-46
46. Day JP. Chemical aspects aluminium chelation therapy by desferrioxamine. In: Taylor A, ed. Aluminium and Other Truce Elements in Renal Disease. Balliere Tindal, Guildford, 1986: 184-192
47. Kontoghiorghes GJ, Sheppard L, Hoffbrand A, Charalambous J, Tikerpae J, Pippard MJ. Iron chelator studies using desferrioxamine and the potential oral chelator 1,2 dimethyI-3-hydroxypyrid-4-one, in normal and iron loaded rats. J Clin Pathol 1987; 40: 404-408
48. Faugere MC, Malluche H. Stainable aluminum and not content reflects bone histology in dialyzed patients. Kidney Int 1986; 30: 717-722
49. Ellis HA, Pang MMC, Mawhinney WHB, Skillen AW. Demonstration of aluminium in iliac bone: correlation between aluminon and solochrome azurine staining techniques with data on flameless absorption spectrophometry. J Clin Pathol 1988; 41: 1171-1175
50. Fernandez Martin JL, Menéndez Rodriguez P, Serrano M, Rebollar A, Menéndez Fraga P, Cannata JB. Sensibilidad y especificidad de las tinciones histoquímicas en la evaluación de depósitos óseos de aluminio. Nefrología 1993; 8: 100-102
51. Van de Vyver F, Visser W, D'Haese P, De Broe ME. Iron overload and bone disease in chronic dialysis patients. Contrib Nephrol 1988; 64: 134-143
52. Van de Vyver F, Visser W, D'Haese P, De Broe ME. Iron overload and bone disease in chronic dialysis patients. Nephrol Dial Transplant 1990; 5: 781-787
53. Cannata JB, Alonso Suárez M, Fernández Martin JL, Díaz López JB. Iron deficiency and intestinal aluminium absorption implications for erythropoietin therapy. Semin Dial 1991; 4: 224-226
54. Ittel TH, Kluge R, Sieberth HG. Enhanced gastrointestinal absorption of aluminium in uraemia: time course and effect of vitamin D. Nephrol Dial Transplant 1988; 3: 617-623
55. Molitoris BA, Froment DH, Mackenzie TA, Huffer WH. Alfrey AC. Citrate: a major factor in the toxicity of orally administered aluminium compounds. Kidney Int 1989; 36: 949-953
56. Fernández Martín JL, Olaizola I, Fernández Menéndez MJ, Miguel MA, Roza M, Cannata JB. Chronic renal failure and age: risk factors for aluminium hydroxide absorption (abstract). Nephrol Dial Transplant 1989; 4: 468
57. Domingo JL, Gómez M, Llobet JM, Corbella J. Influence of some dietary constituents on aluminium absorption and retention in rats. Kidney Int 1991; 39: 598-601
58. Fernández Menéndez MJ, Olaizola I, Díaz López JB, Fernández Solo I, Roza M, Cannata JB. A double risk of aluminium hydroxide intake: Increased aluminium uptake and reduced iron absorption. Trace Elem Med 1991; 8: 167-171
59. Cannata JB, Suárez C, Cuesta MV et al. Gastrointestinal aluminium absorption: is it modulated by the iron-absorptive mechanism? Prao Eur Dial Transplant Assoc 1984; 21: 354-359
60. Fernández Menéndez MJ, Fell GS, Brock JH, Cannata JB. Aluminium uptake by intestinal cells: effect of iron status and precomplexation. Nephrol Dial Transplant 1991; 6: 672-674
61. McGregor S, Fernández Menéndez MJ, Naves ML, Elorriaga JH, Brock JH, Cannata JB. Incorporation de Al y efecto sobre el metabolismo del hierro en la línea celular osteoblasto like (MG 63). Nefrología 1993; 13 (suppl 3): 150-151
62. McGregor S, Fernández Menéndez MJ, Naves ML, Elorriaga JH, Brock JH, Cannata JB. The uptake of aluminium and its effect on iron metabolism in the ostoeoblast like cell line MG 63. Trace Elem Electrol 1994; 11: 187-191
63. Ittel T, Schulpin A, Sieberth H. Relationship between body iron stores and intestinal absorption of aluminium (abstract). Nephrol Dial Transplant 1991; 6: 817
64. Ittel T, Ortmanns A, Sieberth H. Body iron stores does not alter intestinal absorption of aluminium during prolonged dietary exposure (abstract), J Am Soc Nephrol 1994; 5: 851
65. Abreo K, Glass J, Sella ML. Aluminium inhibits hemoglobin synthesis but enhances iron uptake in Friend erythroleukemia cells. Kidney Int 1990; 37: 677-681
66. Olaizola I, Virgós MJ, Fernandez Garcia et al. Aluminium uptake and transport. Relationship with aluminium and iron metabolism in dialysis patients (abstract). Kidney Int 1990: 37: 1611
67. Vanusytel JL, D'Haese P, Couttenye MM, De Broe ME. Higher serum aluminium concentrations in iron depleted patients (letter). Nephrol Dial Transplant 1992; 7: 177
68. Huang JY, Huang CC, Lim PS, Wu MS, Leu ML. Effect of body iron stores on serum aluminium levels in hemodialysis patients. Nephron 1992; 61: 158-162
69. Cannata JB, Olaizola I, Gomez Alonso M, Menéndez Fraga P, Alonso Suárez M, Diaz López JB. Serum aluminium transport and aluminium uptake in chronic renal failure. Role of iron and aluminium metabolism. Nephron 1993; 65: 141-146
70. Olaizola I, Serrano M, Miguel M, Alvarez A, Naves ML, Cannata JB. Evidencias clínico-experimentales sobre la existencia de un mecanismo de retroalimentación en la regulación de la absorción gastrointestinal de aluminio en la insuficiencia renal crónica. Nefrología 1991; 10: 271-276
71. Cannata JB, Gómez Alonso C, Fernández-Menéndez MJ, Fernández Soto I, McGregor S, Brock J. Iron uptake in aluminium overload. In vivo and in vitro studies. Nephrol Dial Transplant 1991; 6: 637-642
72. Rosenlöf K, Fyhrquist F, Tenhunen R. Erythropoietin, aluminium and anaemia in patients on haemodialysis. Lancet 1990; 335: 247-249
73. Losekann A, Ureña P, Khiraoni F, Casadevall N, Zins B, Berech L, Bourdon R et al. Aluminium intoxication in the rat induces partial resistance to the effect of recombinant human erythropoietin. Nephrol Dial Transplant 1990; 5: 258-263
74. Caramelo C, Cannata JB, Rodeles MR et al. Mechanisms of aluminium-induced microcytosis: lessons from accidental aluminum intoxication. Kidney Int 1995; 47: 164-168
75. Cannata JB, Fernández Martin JL, Díaz López JB et al. Influence of iron status in the response to the deferoxamine test. J Am Soc Nephrol 1996; in press